´The health care professionals ànd caregivers also need to be well in order to deliver care for patients’ Andrea Marques speaking at the self-management session at #EULAR2024 @RheumNow https://t.co/BrEHPTbbti

• https://twitter.com/synovialjoints/status/1801925391533158865/photo/1

Autoantibody measures in 5 scandinavian cohorts 6900+ RA pts Four cit-peptides w/ high frequency Cit Fibb36-52 (51%) Cit Fibb60-74-Cit3 (59%) Cit Fil307-324 (54%) Cit Vim60-75-Cit1 (63%) Capture 97% of IgG CCP2+ & 22% IgG CCP2- 42% of all pts + IgG anti-Carb or Acet peptides… https://t.co/yYr6AzgipM https://t.co/6dP6Sgi3yB

• https://twitter.com/i/web/status/1801923768530465116
• https://twitter.com/AurelieRheumo/status/1801923768530465116/photo/1

#EULAR2024 @AilsaBosworth1 highlights the programmes available for pts diagnosed with #RA via the @NRAS_UK platform SMILE-RA and RightStart are great resources for self-management, can highly recommend to all clinicians! @RheumNow https://t.co/SgAMKkcycE

• https://twitter.com/DrMiniDey/status/1801922339904368984/photo/1
• https://twitter.com/DrMiniDey/status/1801922339904368984/photo/1

Just some of the barriers to supporting patients in self-management. Important to note the array of factors at play, some easier to address than others but all should be acknowledged to tailor individual self-management guidance. @RheumNow @ElenaNikiUK #EULAR2024 https://t.co/GJM35l275V

• https://twitter.com/DrMiniDey/status/1801921547432611889/photo/1

« Glucocorticoids are such old drugs and we still use them so much » says Josef Smolen Summary slide from « 75th anniversary of GCd, what have we learnt? » @RheumNow #EULAR2024 https://t.co/XSRt44zupw

• https://twitter.com/AurelieRheumo/status/1801920735344046194/photo/1

From the Be-GIANT cohort, 44.3% of patients met the definition of early axSpA (<2 year symptom). The early axSpA group had younger age and lower frequency of radiographic sacroiliitis. Baseline characteristics and disease activity scores at baseline were similar. Physicians… https://t.co/6stDw8sHiI https://t.co/fjINAc4mw3

• https://twitter.com/i/web/status/1801920535313416598
• https://twitter.com/synovialjoints/status/1801920535313416598/photo/1

#EULAR2024 @ElenaNikiUK highlights the need to treat the patient not the disease, being cognisant of interacting factors incl #comorbidities (Don’t think I’ll ever quite get used to seeing my work being referenced on the big screen!) @RheumNow https://t.co/0tFUR03q8c

• https://twitter.com/DrMiniDey/status/1801919939357343958/photo/1

THE ASSOCIATION BETWEEN DEPRESSION AND BIOLOGIC PRESCRIBING IN AXIAL SPONDYLOARTHRITIS (axSpA): LESSONS FROM AN IRISH axSpA COHORT more likely to have peripheral arthritis enthesitis psoriasis - shoukd we be formally assessing eg Beck’s DI @RheumNow #EULAR2024

FINDINGS ON MRI OF THE SACROILIAC JOINTS 7 YEARS AFTER PREGNANCY IN WOMEN WITH AND WITHOUT POSTPARTUM BUTTOCK/PELVIC PAIN - source of misdiagnosis but not a cause of progressive lesions @RheumNow #EULAR2024 https://t.co/aEvlkMZtQw

• https://twitter.com/drpnash/status/1801916440938705244/photo/1

OP0238-HPR: effectiveness of digital patient education programme for RA self-management Intervention led to improved self-efficacy, w minor improved RA knowledge, #HealthLiteracy & #QoL ➡️such interventions may improve self-management & lower health costs @RheumNow #EULAR2024

Some of the great questions in ICI-induced irAE pathophysiology, from the great Andy Cope @KingsCollegeLon #EULAR2024 @RheumNow https://t.co/aHDqnvhboo

• https://twitter.com/drdavidliew/status/1801916138072498371/photo/1

🙏🏻I am so grateful for @RheumNow's coverage of our research about radiomics in AxSpA ⭐️I believe radiomics has potential and hope it will become a thing in Rheumatology 👇🏻Here is my interview with @bella_mehta about POS 0236 which I presented at #EULAR2024 https://t.co/yvD9yCIzQ8

• Potential Of Radiomics To Predict TNF Ther | RheumNow

DEFINING OVERALL AND SEX-SPECIFIC BASDAI CUT-OFFS FOR DISEASE ACTIVITY STATES IN AXIAL SPONDYLARTHRITIS – RESULTS FROM THE EUROSPA COLLABORATION - more data to stratify for gender at baseline all future AxSpA trials @RheumNow #EULAR2024 https://t.co/nQwCDOxN8R

• https://twitter.com/drpnash/status/1801914600822071787/photo/1

#EULAR2024 #scleroderma #recommend’ns @eular_org #lung #ILD Divide in to #prevention vs #Rx #Immune #suppressive #Rx vs #antifibrotic My thoughts -?other Rx as ⬆️MR Likely all effective early #Rx of skin Improve Risk of #progression▶️ILD @EUSTAR_org @RheumNow https://t.co/4wJyeSEHv3

• https://twitter.com/Janetbirdope/status/1801909893487608243/photo/1
• https://twitter.com/Janetbirdope/status/1801909893487608243/photo/1

EFFICACY AND SAFETY OF IXEKIZUMAB IN CHILDREN WITH ACTIVE JUVENILE PSORIATIC ARTHRITIS AND ENTHESITIS RELATED ARTHRITIS (COSPIRIT-JIA): 16-WEEK RESULTS OF A MULTICENTRE, RANDOMISED, OPEN-LABEL STUDY - IL17 effective & safe in JIA @RheumNow #EULAR2024